The pathogenesis of IgA nephropathy, the most common form of glomerulonephritis in the world, is still largely unknown. The relationship between glomerular IgA deposits and development of renal lesions that precipitate in renal failure, have not been elucidated. On the basis of experimental and clinical observations we hypothesize that in glomerular IgA deposits the structure of IgA and the complexed antigen (IgA-IC) activate glomerular responses that trigger leukocytic infiltration. Proinflammatory cytokines from infiltrating cells induce or augment the generation of growth factors. The interplay of synergistic and antagonistic elements within this network alter the composition and production of the extracellular matrix that consummates in glomerular sclerosis, interstitial fibrosis, and renal failure. A comprehensive human IgA-mediated nephropathy experimental model will be developed in a T and B lymphocytes-deficient, Recombination Activation Gene-disrupted (knockout), mice. This model will provide a framework for elucidating in vivo the cellular and molecular mechanisms that are associated with glomerular human IgA immune deposits. To develop the model and evaluate the hypothesis, the following specific aims will be addressed: 1. We will construct human IgA1 and IgA2 as antigen-specific chimeric antibodies for formation of human IgA immune complexes. 2. We will elucidate the primary mechanisms that lead to human IgA-IC glomerular localization. 3. We will identify the mediators of glomerular responses to human IgA-IC by examining:complement deposition, procoagulant activation, phenotypic and genotypic expression of Selectins, and chemokines. 4. We will determine the nephritogenic profile of proinflammatory cytokines and growth factors in renal tissues with IgA immune deposits. 5. We will characterize in a chronic model of human IgA nephropathy the differential expression of extracellular matrix genes involved in the progressive stages of fibrosis associated with renal failure. These studies will provide an insight into cellular and molecular mechanisms underlying the pathogenesis of IgA nephropathy that can be targeted for development of therapy and prevention of progression to renal failure.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK049361-02
Application #
2150078
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1994-09-30
Project End
1998-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Rhode Island Hospital (Providence, RI)
Department
Type
DUNS #
161202122
City
Providence
State
RI
Country
United States
Zip Code
02903
Yano, N; Habib, N A; Fadden, K J et al. (2001) Profiling the adult human liver transcriptome: analysis by cDNA array hybridization. J Hepatol 35:178-86
Yano, N; Endoh, M; Fadden, K et al. (2000) Comprehensive gene expression profile of the adult human renal cortex: analysis by cDNA array hybridization. Kidney Int 57:1452-9
Sanada, H; Asico, L D; Shigetomi, S et al. (2000) The effect of docarpamine, a dopamine pro-drug, on blood pressure and catecholamine levels in spontaneously hypertensive rats. Clin Exp Hypertens 22:419-29
Aoki, Y; Aviles, D H; Jose, P A (2000) Biphasic effects of dopamine on 86rubidium uptake in rat renal proximal tubules. Clin Exp Hypertens 22:289-301
Yano, N; Endoh, M; Nomoto, Y et al. (1997) Phenotypic characterization of cytokine expression in patients with IgA nephropathy. J Clin Immunol 17:396-403
Albrecht, F E; Drago, J; Felder, R A et al. (1996) Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 97:2283-8
Rifai, A; Brysch, W; Fadden, K et al. (1996) Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice. Am J Pathol 149:717-25
Yao, L P; Jose, P A (1995) Developmental renal hemodynamics. Pediatr Nephrol 9:632-7
Montinaro, V; Aventaggiato, L; Cavallo, T et al. (1995) Evolution of renal injury in a chronic model of IgA immune-complex-associated nephropathy. Nephrol Dial Transplant 10:2035-42
Jose, P A; Yu, P Y; Yamaguchi, I et al. (1995) Dopamine D1 receptor regulation of phospholipase C. Hypertens Res 18 Suppl 1:S39-42